GENE POLYMORPHISM OF MATRIX METALLOPROTEINASE 9 AND TISSUE INHIBITOR OF METALLOPROTEASE 1 IN DEVELOPMENT OF POST-OPERATION ATRIAL FIBRILLATION
Abstract
To assess association of gene polymorphism of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 with development of atrial fibrillation after the coronary artery bypass grafting surgery, 80 patients with stable coronary heart disease were examined.
About the Authors
O. A. Rubanenko
ГБОУ ВПО «Самарский государственный медицинский университет» Министерства здравоохранения РФ
Russian Federation
Russian Federation
S. A. Shavkunov
ММУ Самарской области «Медико-санитарная часть № 2»
Russian Federation
Russian Federation
N. A. Kirichenko
ГБОУ ВПО «Самарский государственный медицинский университет» Министерства здравоохранения РФ
Russian Federation
Russian Federation
T. M. Kuzmina
ГБОУ ВПО «Самарский государственный медицинский университет» Министерства здравоохранения РФ
Russian Federation
Russian Federation
E. A. Sadomova
ГБОУ ВПО «Самарский государственный медицинский университет» Министерства здравоохранения РФ
Russian Federation
Russian Federation
References
1. Philip F., Becker M., Galla J. et al. Transient post-operative atrial fibrillation predicts short and long term adverse events following CAB G // CardiovascDiagnTher. 2014; 4(5): 365-72.
2. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications // Circ Arrhythm Electrophysiol. 2008; 1: 62-73.
3. Huxley R.R., Lopez F.L., MacLehose R.F. et al. Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study // PLoS One. 2013; 8(3): e59052.
4. Lubitz S., Lunetta K., Lin H. et al. Novel genetic markers with atrial fibrillation in Europeans and Japanese // J Am Coll Cardiol. 2014; 63(12): 1200-10.
5. Gai X., Lan X., Luo Z. et al. Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients // Clin Chim Acta. 2009; 408(1-2): 105-9.
6. Ахмедов В.А., Долгих В.Т., Наумов Д.В., Нечипоренко Н.А. Участие матриксной металлопротеиназы-9 и TIMP-1 в развитии пароксизмов фибрилляции предсердий у больных с метаболическим синдромом // Пат. физиол. 2013; 4: 46-50.
7. Brunner S., Kim J.O., Methe H. et al. Relation of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio in Peripheral Circulating CD14+ Monocytes to Progression of Coronary Artery Disease // American Journal of Cardiology. 2010; 105(4): 429- 434.
8. Frantz S., Störk S., Michels K. et al. Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality // European Journal of Heart Failure. 2008; 10(4): 388-395.
9. Thorén E., Hellgren L., Granath F. et al. Postoperative atrial fibrillation predicts cause-specific late mortality after coronary surgery // Scand Cardiovasc J. 2014; 48(2): 71-8.
10. Shen J., Lall S., Zheng V. et al. The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over two decades // J Thorac Cardiovasc Surg 2011; 141: 559-570.
11. Parsaee M., Moradi B., Esmaeilzadeh M. et al. New onset atrial fibrillation after coronary artery bypasses grafting; an evaluation of mechanical left atrial function // Arch Iran Med. 2014; 17(7): 501-6.
12. Jakubova M., Mitro P., Stancak B. et al. The occurrence of postoperative atrial fibrillation according to different surgical settings in cardiac surgery patients // Interact Cardiovasc Thorac Surg 2012; 15: 1007-12.
13. Wasmer K., Unrath M., Köbe J. et al. Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease // Int J Cardiol. 2015; 199: 223-8.
14. Davoodi S., Karimi A., Ahmadi S.H. et al. Early outcome of off-pump versus on-pump coronary revascularization // Pan Afr Med J. 2014; 17: 309.
15. Wittwer T., Sabashnikov A., Rahmanian P.B. et al. Less invasive coronary artery revascularization with a minimized extracorporeal circulation system: preliminary results of a comparative study with off-pump-procedures // J Cardiothorac Surg. 2013; 8: 75.
16. Oktay V., Baydar O., Sinan Ü.Y. et al. The effect of oxidative stress related with ischemia-reperfusion damage on the pathogenesis of atrial fibrillationdeveloping after coronary artery bypass graft surgery // Turk Kardiyol Dern Ars. 2014; 42(5): 419-25.
17. Kato K., Oguri M., Hibino T. et al. Genetic factors for lone atrial fibrillation // Int J Mol Med. 2007; 19(6): 933-9.
18. Kertai M.D., Li Y.J., Ji Y. et al. Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery // Am Heart J. 2015; 170(3): 580-90.
19. Lin C.S., Pan C.H. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation // Cell Mol Life Sci. 2008; 65(10): 1489-508.
20. Heymans S., Schroen B., Vermeersch P. et al. Increased cardiac expression of tissue inhibitor of metalloproteinase 1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart // Circulation. 2005; 112(8): 11361144
21. Miner E.C., Miller W.L. A look between the cardiomyocytes: the extracellular matrix n heart failure // Mayo. Clin. Proc. 2006; 81: 71-76.
22. Bittar M.N., Carey J.A., Barnard J. et al. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery // Heart Surg Forum. 2005; 8(3): E140-5.
23. Frustaci A., Chimenti C., Bellocci F. et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation // Circulation 1997; 96: 1180-1184.
Review
For citations:
Rubanenko O.A., Shavkunov S.A., Kirichenko N.A., Kuzmina T.M., Sadomova E.A. GENE POLYMORPHISM OF MATRIX METALLOPROTEINASE 9 AND TISSUE INHIBITOR OF METALLOPROTEASE 1 IN DEVELOPMENT OF POST-OPERATION ATRIAL FIBRILLATION. Journal of Arrhythmology. 2015;(82):21-26. (In Russ.)
Views:
131
Email this article 